<DOC>
	<DOCNO>NCT00263276</DOCNO>
	<brief_summary>The purpose clinical research study learn BMS-512148 effective control blood sugar level determine HbA1c fast plasma glucose patient diagnose Type 2 diabetes . Patients first try control diabetes diet exercise previously treat diabetes ( short period time acceptable ) . The safety BMS512148 also study</brief_summary>
	<brief_title>A Trial BMS-512148 Patients With Type 2 Diabetes Mellitus</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<criteria>Patients Type 2 diabetes mellitus inadequate glycemic control diet exercise . HbA1c &gt; = 7 % &lt; =10 % . Patient either previously treat antihyperglycemic medication treat &lt; 30 day since diagnosis receive less 3 consecutive dos 7 nonconsecutive dos last 30 day . Cpeptide &gt; 1.0 ng/ml Body Mass Index &lt; = 40 kg/m2 Serum creatinine &lt; 1.5 mg/dL men &lt; 1.4 mg/dL woman . No overt proteinuria ( microalbumin/creatinine ratio must &lt; 300 mg/g Unstable renal disease Patients significant liver disease include chronic active hepatitis Within last 6 month follow cardiovascular event : myocardial infarction , unstable angina , unstable CHF , NYHA Class III IV CHF , TIA , unstable arrhythmia cardiac revascularization surgery . Subjects clinically significant anemia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>